<DOC>
	<DOCNO>NCT01929538</DOCNO>
	<brief_summary>Benign biliary stricture cause chronic pancreatitis endoscopically treat cover self-expandable metal stent ( cSEMS ) .The purpose prospective randomize study define optimal duration stenting diameter cSEMS .</brief_summary>
	<brief_title>Covered Metal Stent Benign Biliary Stricture Caused Chronic Pancreatitis</brief_title>
	<detailed_description>All consecutive patient admit ERCP treat benign biliary stricture cause chronic pancreatitis without acute pancreatitis prospectively enrol study . The age gender patient aetiology pancreatitis record . At initial presentation , clinical laboratory finding record include liver function test , abdominal pain , jaundice cholangitis . Pancreatic calcification document abdominal computed tomography . Patients malignancy , cirrhosis , acute/chronic hepatitis abnormal hepatic imaging study exclude . Patients first attack acute pancreatitis exclude . The approval ethic committee hospital obtain . An informed consent obtain patient . All patient prepare sedated ERCP per standard medical practice hospital . At initial ERCP , endoscopic sphincterotomy perform presence/absence bile duct stone stricture treatment stone record . A pancreatic stent insert indicated . For initial ERCP patient randomize two group : receive 10 mm diameter cSEMS receive 12 mm diameter cSEMS bile duct . For randomization , seal envelope use . The length cSEMS record . Further ERCP stent removal perform six month patient 12 mm diameter cSEMS twelve month patient 10 mm diameter cSEMS . In case stent migration follow-up , stent replace similar new cSEMS . If pancreatic stent place , removal replacement handle accord hospital practice . After ERCP procedure , patient stay hospital monitoring occurrence primary complication acute pancreatitis cholangitis , bile leak , bleed perforation . Plasma amylase activity measure day &gt; 4h ERCP . Post-ERCP pancreatitis define presence abdominal pain attributable acute pancreatitis plasma amylase level least three time upper limit reference interval . The treatment primary complication record . Follow-up Clinical response ( adequate biliary drainage ) recurrent stricture formation primary endpoint study . Therefore , blood liver function test ( bilirubin , alkaline phosphatase ) well minimum diameter common bile duct area stricture , maximum diameter common bile duct stricture length stricture measure ERCPs time initial ERCP removal cSEMS . Blood liver function test measure morning ERCPs ; exact width lengths mm : obtain comparison width lengths diameter scope . In addition , blood liver function test measure abdominal ultrasonography perform follow-up six month two year stent removal . Morbidity mortality additional endpoint study . Therefore , complication ( death , stent occlusion , dislodgement migration , cholangitis , hemobilia , stone formation stent ) , management complication , admission time , surgical intervention additional care need monitor record follow-up time . Patients ask contact physician time symptom fever , abdominal pain jaundice occur .</detailed_description>
	<mesh_term>Pancreatitis</mesh_term>
	<mesh_term>Constriction , Pathologic</mesh_term>
	<mesh_term>Pancreatitis , Chronic</mesh_term>
	<mesh_term>Cholestasis</mesh_term>
	<criteria>Benign biliary stricture cause chronic pancreatitis Malignancy , cirrhosis , acute/chronic hepatitis abnormal hepatic imaging . First attack acute pancreatitis</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Chronic pancreatitis</keyword>
	<keyword>Biliary stricture</keyword>
	<keyword>Endoscopic treatment</keyword>
	<keyword>cSEMS</keyword>
</DOC>